Your browser doesn't support javascript.
loading
Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial.
Fosbøl, Marie Øbro; Kurbegovic, Sorel; Johannesen, Helle Hjorth; Røder, Martin Andreas; Hansen, Adam Espe; Mortensen, Jann; Loft, Annika; Petersen, Peter Meidahl; Madsen, Jacob; Brasso, Klaus; Kjaer, Andreas.
Afiliação
  • Fosbøl MØ; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
  • Kurbegovic S; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
  • Johannesen HH; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
  • Røder MA; Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen, Denmark; and.
  • Hansen AE; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
  • Mortensen J; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
  • Loft A; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
  • Petersen PM; Department of Clinical Oncology, Rigshospitalet, Copenhagen, Denmark.
  • Madsen J; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
  • Brasso K; Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen, Denmark; and.
  • Kjaer A; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark akjaer@sund.ku.dk.
J Nucl Med ; 62(3): 354-359, 2021 03.
Article em En | MEDLINE | ID: mdl-32764119
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Imageamento por Ressonância Magnética / Tomografia por Emissão de Pósitrons / Receptores de Ativador de Plasminogênio Tipo Uroquinase Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Imageamento por Ressonância Magnética / Tomografia por Emissão de Pósitrons / Receptores de Ativador de Plasminogênio Tipo Uroquinase Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article